Vaxcyte Announces Publication of Preclinical Data Supporting the Potential of VAX-24 for the Prevention of Invasive Pneumococcal Disease by Carolyn Helms | May 10, 2021 | Portfolio News
Checkmate Pharmaceuticals Announces Clinical Supply Agreement with Regeneron to Evaluate Vidutolimod (CMP-001) in Combination with Libtayo® (cemiplimab) by Carolyn Helms | May 10, 2021 | Portfolio News
Inozyme Pharma Presents Preclinical Data Suggesting Utility of INZ-701 as a Potential Treatment for ABCC6 Deficiency by Carolyn Helms | May 7, 2021 | Portfolio News
Talaris Therapeutics Announces Pricing of Initial Public Offering by Carolyn Helms | May 6, 2021 | Portfolio News
Axonics® Reports First Quarter 2021 Financial Results by Carolyn Helms | May 6, 2021 | Portfolio News
